Medlive Technology Co Ltd
HKEX:2192

Watchlist Manager
Medlive Technology Co Ltd Logo
Medlive Technology Co Ltd
HKEX:2192
Watchlist
Price: 9.76 HKD -1.71%
Market Cap: 7.2B HKD
Have any thoughts about
Medlive Technology Co Ltd?
Write Note

Medlive Technology Co Ltd
Long-Term Investments

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Medlive Technology Co Ltd
Long-Term Investments Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Long-Term Investments CAGR 3Y CAGR 5Y CAGR 10Y
Medlive Technology Co Ltd
HKEX:2192
Long-Term Investments
ÂĄ42.4m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Y
Yidu Tech Inc
HKEX:2158
Long-Term Investments
ÂĄ245.6m
CAGR 3-Years
261%
CAGR 5-Years
201%
CAGR 10-Years
N/A
Guiyang Longmaster Information & Technology Co Ltd
SZSE:300288
Long-Term Investments
ÂĄ412.5m
CAGR 3-Years
5%
CAGR 5-Years
5%
CAGR 10-Years
40%
B-SOFT Co Ltd
SZSE:300451
Long-Term Investments
ÂĄ281.3m
CAGR 3-Years
-11%
CAGR 5-Years
-3%
CAGR 10-Years
N/A
Heren Health Co Ltd
SZSE:300550
Long-Term Investments
ÂĄ53.3m
CAGR 3-Years
-7%
CAGR 5-Years
-6%
CAGR 10-Years
N/A
Winning Health Technology Group Co Ltd
SZSE:300253
Long-Term Investments
ÂĄ929.4m
CAGR 3-Years
2%
CAGR 5-Years
0%
CAGR 10-Years
69%
No Stocks Found

Medlive Technology Co Ltd
Glance View

Market Cap
7.1B HKD
Industry
Health Care

Medlive Technology Co., Ltd. operates as an investment holding company. The company is headquartered in Beijing, Beijing. The company went IPO on 2021-07-15. The firm mainly operates three segments. Its Precision Marketing and Corporate Solutions segment provides precision marketing solutions and corporate solutions. Its precision marketing solutions include digital detailing, digital marketing consulting and digital content creation services. Its revenue of its corporate solutions is primarily software as a service (SaaS). The Medical Knowledge Solutions segment mainly provides professional medical information and medical software services. The Intelligent Patient Management Solutions segment mainly provides online patient consultation and prescription services and patient management services. The firm mainly conducts its business within domestic market.

Intrinsic Value
6.74 HKD
Overvaluation 31%
Intrinsic Value
Price

See Also

What is Medlive Technology Co Ltd's Long-Term Investments?
Long-Term Investments
42.4m CNY

Based on the financial report for Dec 31, 2023, Medlive Technology Co Ltd's Long-Term Investments amounts to 42.4m CNY.

What is Medlive Technology Co Ltd's Long-Term Investments growth rate?
Long-Term Investments CAGR 1Y
-54%

Over the last year, the Long-Term Investments growth was -54%.

Back to Top